Open AccessPsoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study
Author(s) -
Anna Campanati,
Federico Diotallevi,
Giulia Radi,
Elisa Molinelli,
Valerio Brisigotti,
Emanuela Martina,
Matteo Paolinelli,
Tommaso Bianchelli,
C. Cosimo S. Covi,
Marta Bartezaghi,
Annamaria Offidani
Publication year - 2021
Publication title -
european journal of dermatology/ejd. european journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.48
H-Index - 71
eISSN - 1952-4013
pISSN - 1167-1122
DOI - 10.1684/ejd.2021.4150
Subject(s) - secukinumab , medicine , psoriasis area and severity index , psoriasis , body mass index , body surface area , malondialdehyde , gastroenterology , population , immunology , surgery , psoriatic arthritis , oxidative stress , environmental health